Tag: Population Health

Webinar – Understanding the connections between air pollution and rheumatic disease

Posted on by pathwp

Join us for an upcoming CanPath webinar that considers the connections between air pollution and rheumatic disease. February 20, 2025   ~   12pmEST/1pmAST Registration: https://bit.ly/40YZNBx About the webinar Join Dr. Sasha Bernatsky, a leading researcher in rheumatic disease and environmental health, as she delves into how environmental exposures impact autoimmunity and inflammation. Drawing on her extensive work with CanPath, Dr. Bernatsky has demonstrated potential associations between air pollutants, including PM2.5, and autoimmunity and rheumatic diseases. In this session, Dr. Bernatsky will also preview her new research on the impact of wildfire smoke and temperature extremes on rheumatic diseases in Canada, supported by recent CIHR funding. Researchers interested in environmental health, autoimmune diseases, and leveraging population-based data for innovative studies won’t want to miss this opportunity to gain valuable insights and explore future directions in the field. About the presenter Dr. Sasha Bernatsky Sasha Bernatsky, MD PhD, is a rheumatologist, a James McGill Professor of Medicine at McGill University and a Senior Scientist of the Centre for Health Outcomes Research at the Research Institute of the McGill University Health Centre.  Dr. Bernatsky is also affiliated with the McGill Environmental Epidemiology Research Group, a network with expertise in pharmacology/toxicology, and environmental sciences. She is a member of the Canadian Urban Environmental Health Research Consortium (CANUE), the Systemic Lupus International Collaborating Clinics (SLICC), and the Canadian Network for Improved Outcomes in SLE (CaNIOS). Her research focuses mainly on outcomes in rheumatic diseases, pharmacoepidemiology, and air pollution’s effects on health.

Pan-Canadian Cancer Data Strategy

Posted on by pathwp

The Canadian Cancer Society (CCS) and Canadian Partnership Against Cancer (CPAC) have launched the Pan-Canadian Cancer Data Strategy that will guide efforts to enhance the collection, integration and use of cancer data. “CPAC and CCS have worked with various partners, including provincial and territorial cancer agencies and programs, healthcare organizations, First Nations, Inuit and Métis partners, researchers, policymakers and people with lived cancer experience to create a cancer-specific data strategy that includes: a framework to guide the mission, vision, values and success factors for improvements in cancer data three priorities for action and investment including: improving the efficiency, timeliness and quality of data capture and access enhancing linkages to current data filling gaps in current data collection and availability a section on the importance of First Nations, Inuit and Métis data sovereignty, with examples of First Nations, Inuit and Métis-led efforts to improve data and data governance.” CanPath, and its seven regional cohorts including Atlantic PATH, are proud to be represented in the new Pan-Canadian Cancer Data Strategy.  We’re committed to filling gaps in data on risk factors to guide cancer prevention efforts.  CPAC Press Release: https://www.partnershipagainstcancer.ca/about-us/corporate-resources-publications/pan-canadian-cancer-data-strategy/

Genome BC’s Annual Genomics Forum – May 3, 2023

Posted on by pathwp

CanPath National Scientific Director, Dr. Philip Awadalla and BC Generations Scientific Director, Dr. Parveen Bhatti will be speaking in session 4, “All In: Using Large Population-Based Genomics Studies to Inform Patient Care.”  Wednesday, May 3rd: 3:00-4:30pm PST / 6:00-7:30EST / 7:00-8:30pmAST Registration: https://events.genomebc.ca/genomics-forum-2023/ Session Description: “Large population-based studies have taken place in several countries. Examples include All of Us (USA), 100,000 Genomes Project (UK) and Australian Genomics. This session will explore how these countries have made their project successful and how Canada can leverage already existing data and samples to have its own large cohort initiative — one that supports the development of disease screening, diagnostic, prevention and treatment, as well as inform public health policies for our diverse population.” Speakers: Zsuzsanna Hollander (Moderator) – Genome British Columbia Philip Awadalla (Presenter) – CanPath (Canadian Partnership for Tomorrow’s Health) Parveen Bhatti (Presenter) – BC Cancer Research Institute Anastasia Wise – All of Us Research Program, National Institutes of Health Tiffany Boughtwood – Australian Genomics About the Event: “Precision health care promises to target the right treatments to the right patients at the right time. And while genomics technologies have been used to effectively treat patients in health research for decades, thereby revolutionizing patient care, there are areas where these transformational technologies have not yet had a major impact. Join Genome BC on May 3, 2023, this year’s Annual Genomics Forum as we discuss the power and hurdles of integrating genomics into patient management and how we can ensure maximum value is derived from samples and patient data. Other countries have been leading the way in translational genomics research through initiatives such as “All of Us”, inviting one million people across the United States to help build one of the most diverse health databases in history. Australia Genomics has established a national collaboration supporting the translation of genomic research into clinical practice. And Genomics England’s initiative to sequence 100,000 genomes of patients affected by rare diseases or cancer is providing groundbreaking insights and continued findings into the role genomics can play in health care. Though efforts such as these have yet to materialize in Canada, can we leverage already existing biobanks and health data administration systems to make gains and fulfil the promise of precision health for Canadians? Let us learn how we can individually and collectively contribute to filling this gap while ensuring that research and health care advances are equitable to all.” https://events.genomebc.ca/genomics-forum-2023/

Webinar: Advancing Equity and EDIA Through Health Services and Population Health Research

Posted on by pathwp

An upcoming webinar presented by the Canadian Institutes of Health Research (CIHR) and Canadian Association for Heath Services and Policy Research (CAHSPR). Advancing Equity and EDIA through Health Services and Population Health Research Presentations from Dr. Katie Aubrecht and Dr. Andrew Pinto. April 24th, 1-230pm (AST) Registration: https://events.eply.com/2023HSPRTalksApril24 “Improving equity in health care and health outcomes is a goal held by many and one that is increasingly prioritized by a range of stakeholders. Health services and policy research (HSPR) and population and public health research (PPHR) have important roles to play in advancing health equity goals. To maximize their contribution to improving health equity, equity, diversity, inclusion, and accessibility (EDIA) within these fields must also advance. This webinar will present the concepts and histories of these two distinct but interrelated concepts (health equity and EDIA), offer possible strategies and actions for the HSPR and PPHR communities to incorporate equity and EDIA in their work, and foster discussion among people interested in improving their contribution to a more equitable society. The session will draw upon two recent papers, available for reading prior to the session here and here, and reflects a partnership between CAHSPR and CIHR’s Institutes of Health Services and Policy Research (IHSPR) and Population and Public Health (IPPH).” Additional info: https://s3.ca-central-1.amazonaws.com/eply-client-files/191/AccountFiles/Documents/HSPR/HSPR%20Talks%20Advancing%20Equity%20and%20EDIA.pdf    

CanPath Researcher Feature – Ace Chan

Posted on by pathwp

Check out CanPath’s Researcher Feature of University of British Columbia School of Population and Public Health’s PhD student, Ace Chan.  Ace’s research interests include sexual and gender minority (SGM) health, creating inclusive and accessible healthcare spaces for SGM folks, and they strive towards providing scientific evidence to achieve health equity in marginalized populations. Ace’s research will use CanPath data to explore the rates of alcohol consumption, tobacco use, cancer risk factors, and cancer diagnoses in gender minority people compared to non-gender minority people. Researcher Feature Interview: https://canpath.ca/2023/03/researcher-feature-ace-chan/ Approved Project – Primary Prevention of Cancer-Causing Substance Use in Gender Minority People in Canada: https://canpath.ca/project/dummer-chan-2022/